SyntekaBio Inc (226330) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.169x

Based on the latest financial reports, SyntekaBio Inc (226330) has a cash flow conversion efficiency ratio of -0.169x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.01 Billion ≈ $-1.36 Million USD) by net assets (₩11.90 Billion ≈ $8.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 226330 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

SyntekaBio Inc - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how SyntekaBio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SyntekaBio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SyntekaBio Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Keller Group PLC LSE:KLR	0.077x
DAP Corporation KQ:066900	0.040x
BBC Co. Ltd. KQ:318410	0.013x
Sinergi Megah Internusa Tbk PT JK:NUSA	-0.204x
Hateks Hatay Tekstil Isletmeleri AS IS:HATEK	-0.099x
Euroholdings Ltd. NASDAQ:EHLD	0.148x
Shenzhen Properties & Resources Development Group Ltd SHE:200011	-0.112x
Tontek Design Technology Ltd TWO:5487	0.022x

Annual Cash Flow Conversion Efficiency for SyntekaBio Inc (2017–2024)

The table below shows the annual cash flow conversion efficiency of SyntekaBio Inc from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see SyntekaBio Inc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.94 Billion ≈ $16.90 Million	₩-10.51 Billion ≈ $-7.12 Million	-0.421x	-62.87%
2023-12-31	₩31.23 Billion ≈ $21.16 Million	₩-8.08 Billion ≈ $-5.47 Million	-0.259x	+4.38%
2022-12-31	₩31.46 Billion ≈ $21.32 Million	₩-8.51 Billion ≈ $-5.77 Million	-0.271x	-23.73%
2021-12-31	₩27.63 Billion ≈ $18.72 Million	₩-6.04 Billion ≈ $-4.09 Million	-0.219x	-94.57%
2020-12-31	₩41.54 Billion ≈ $28.15 Million	₩-4.67 Billion ≈ $-3.16 Million	-0.112x	-57.95%
2019-12-31	₩46.11 Billion ≈ $31.25 Million	₩-3.28 Billion ≈ $-2.22 Million	-0.071x	+95.06%
2018-12-31	₩1.64 Billion ≈ $1.11 Million	₩-2.37 Billion ≈ $-1.60 Million	-1.441x	-261.66%
2017-12-31	₩-2.79 Billion ≈ $-1.89 Million	₩-2.49 Billion ≈ $-1.69 Million	0.891x	--

About SyntekaBio Inc

KQ:226330 Korea Health Information Services

Market Cap

$22.54 Million

₩33.26 Billion KRW

Market Cap Rank

#24751 Global

#1761 in Korea

Share Price

₩1822.00

Change (1 day)

-6.61%

52-Week Range

₩1811.00 - ₩7870.00

All Time High

₩43250.00